What is an ancillary study?
A CCTRN ancillary study is one that uses CCTRN resources and derives funding from a source other than CCTRN contract funds. Examples include studies funded by investigator-initiated NIH research awards (R01s), grants from academic institutions, private sources (e.g., drug companies), or those performed at no cost (generally because of the special interest of a researcher). A study that involves the collection of new data, either directly from participants or from previously collected samples, images, or other sources (e.g., exercise data), is an ancillary study, regardless of the method of funding. A study that provides external funding for the Data Coordinating Center, one or more Clinical Centers, or a Core Lab, is an ancillary study.
Approved Ancillary Studies
|
No |
Investigator |
Study Title |
CCTRN Trial Population |
|
1 |
Mark Segal/Carl Pepine |
Functional Characteristics of Autologous BMCs and their Relationship to Clinical Outcomes in CCTRN (FCAS) |
TIME & LateTIME |
|
2 |
Maria Graca-Cabreira |
CPAS Molecular and Cellular Profile of BMCs in Heart Disease (CPAS) |
TIME, LateTIME, & FOCUS |
|
3 |
Maria Graca-Cabreira |
The Role of Cellular Senescence on Stem Cell Function in Peripheral Arterial Disease Patients |
PACE |
|
4 |
Matt Springer |
R01 pilot study |
TIME & LateTIME |
|
5
|
James Willerson/Doris Taylor |
Defining MicroRNA Profiles in FOCUS |
FOCUS |
|
6 |
Jesse Jokerst |
Gene Expression Profiles and Stem Cell Markers_TIME and LateTIME |
TIME & LateTIME |
|
7 |
James Willerson/Doris Taylor/Jim Martin |
VALUE-CONCERT: Evaluating peripheral blood and tissue microRNAs in CONCERT |
CONCERT-HF |
|
8 |
Doris Taylor/James Willerson |
BONUS-CONCERT: Flow Cytometry |
CONCERT-HF |
|
9 |
Doris Taylor/James Willerson |
Research Strategy for Research on Sex/Gender Differences |
TIME/LateTIME/FOCUS |
|
10 |
Doris Taylor/James Willerson/Micheline Resende |
Peripheral blood cell immunophenotyping profiles and potency in Stem Cell Injection in Cancer Survivors |
SENECA |
|
11 |
Connor O'Brien/Phil Yang |
Evaluating the Cardioprotective Effects of Exosomes During Stem Cell Therapy |
SENECA |
|
12 |
Ngan Huang/Phil Yang
|
Functional Assessment of Induced Pluripotent Stem Cell-Derived Endothelial Cells from Patients with Peripheral Arterial Disease |
PACE |
|
13 |
Michelene Resende/ Doris Taylor |
CCTRN-FOCUS Peripheral Blood Cytokine Analyses |
FOCUS |
|
14 |
Maria Graca-Cabreira/Doris Taylor |
Influence of polymorphisms in the INK4 Ch9p21 genetic locus on ANRIL transcriptional activity in cardiovascular disease |
PACE |
|
15 |
Thomas Bollenbach/Camila Hochman Mendez |
Multi-platform analyses to Identify Efficacy Signatures in Cell-Based Therapy Trials of Patients with Ischemic Heart Disease |
TIME, LateTIME, FOCUS, PACE |
